Seeking Alpha

Endo Health (ENDP +4.8%) settles two patent lawsuits with Watson Pharmaceuticals (WPI +1.8%)...

Endo Health (ENDP +4.8%) settles two patent lawsuits with Watson Pharmaceuticals (WPI +1.8%) that will allow the latter to launch a generic version of Lidoderm, Endo's $1B+ pain-relieving patch, from September 2013, pending FDA approval. Watson will pay Endo a quarter of the gross profit as royalty.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|